Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NF54/iGP3 Malaria Challenge in Healthy Adults
NCT06881732Phase 1Not yet recruiting
- Sponsor
- University of Melbourne
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Melbourne. Primary endpoint: Infectivity, safety and tolerability of mosquito bite sporozoite challenge. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06881732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06881732.